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Summary.—A method is presented to evaluate the influence of statistical errors 
and inherent variation on the determination of mitotic and labelling indices of 
human tumours. In most of the experiments reported here, sufficient cells were 
counted to yield a statistical error which is small in comparison to the inherent 
differences in the proliferative indices, both between different sites in the same 
tumour and between different tumours of the same histological type. These inherent 
fluctuations are, therefore, a critical factor in cell kinetic studies of human tumours. 
T H E study of cell population kinetics 
ideally requires tissue samples which are 
large, or multiple, or both. Generally, 
this does not pose a serious problem when 
the subject of research is an experimental 
tumour population. Bu t the goal of most 
tumour cell population studies is a better 
understanding of human cancer, and 
there is no realistic substitute for i n -
vestigating human tumours as they occur 
in the patient, whenever this is feasible. 
Natural ly , clinical research must be sub-
ordinated to a proper concern for the 
comfort of an ailing patient. I t follows 
that the question of statistical accuracy 
must be considered very carefully; we 
must make the best of the l imited samples 
available. I n such circumstances the urge 
to strain after conclusions is strong, 
and accordingly the need to be aware of 
covert statistical errors is more essential 
than usual. I n this paper we examine 
different sources of statistical uncertainty 
in two important parameters of cell 
population kinetics, namely the labelling 
and mitot ic indices. 
M A T E R I A L 
The material comprises 5 cases of advanced, 
resected nephroblastoma (Wilms' tumour) 
on which multiple mitotic indices were 
determined: 6 cases of early invasive but 
operable mammary carcinoma, on which 
both mitotic and labelling indices were 
determined at multiple sites (both types 
of mammary carcinoma were received as 
excision biopsies for rapid diagnosis); 2 cases 
of metastatic axillary lymph node deposits 
of mammary carcinoma, on which were 
determined the mitotic index and the 
labelling index both at multiple sites; and 
2 cases of colorectal carcinoma on which 
the mitotic index was found, again at 
multiple sites. 
M E T H O D S 
The mitotic index was determined on 
spatially distinct blocks in the cases of 
nephroblastoma and colorectal carcinoma, 
and retrospectively from stored histological 
sections in the case of mammary carcinoma 
except those which were also sampled for 
labelling, where again spatially distinct 
blocks were chosen. After primary fixation 
in formol-saline followed by secondary 
fixation in mercuric chloride (except for 
labelled blocks, which were fixed in Carnoy's 
fluid) sections were cut and stained by 
standard methods. 
The labelling index was determined by 
culturing 1-mm3 fragments of tumour in 
3 ml of WTaymouth's medium (Wellcome) 
supplemented by 15% foetal bovine serum 
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(Flow Laboratories) and with [ 3 H]-thy mi dine 
(Radiochemical Centre, Amersham) at a 
concentration of 10 /xCi/ml. The culture was 
maintained for 30 min, after which the 
fragments were fixed for a short period in 
Carnoy's fluid and finally sectioned at 
3 ^m. The sections were clipped for auto-
radiography in Ilford K2 emulsion and 
exposed for 2 weeks. 
S T A T I S T I C A L A N A L Y S I S 
Mitotic and labelling indices (7M and 
Is, respectively) are estimated from experi-
mentally determined proportions, p = rjn, 
where r is the number of cells which, in the 
one case, are in mitosis and, in the other, 
are labelled, and n is the total number of 
observed cells. The quantity r is subject to 
binomial statistics; accordingly, the variance 
of p is equal to (1 — <CJP»/w> where 
the mean <j9> of p is equal to IM or Zs*-
Since, in the cases which will be considered, 
IM and Is are of the order 0-005-0-05, the 
distributions actually reduce to Poisson 
distributions and the variance of p can be 
set equal to (p)jn. Whenever r is sufficiently 
large (e.g. > 10) the situation is further 
simplified; and the distribution of p is 
approximately normal, with variance (j>yjn. 
These considerations apply to the ideal 
case where samples are taken from the 
same site in the same tumour. I n practice 
the standard deviation of the observed 
ratio rjn wil l be increased, as we shall 
show, due to differences in IM or 1$ either 
(a) between samples taken from different 
tumours, or (b) between samples taken from 
different sites in the same tumour. I n other 
words, the actual standard deviation of ex-
perimentally determined values p is due not 
only to the sampling error of finite cell 
counts, but also to inherent variations in IM 
and Is, within tumours and between tumours. 
Our study is concerned with an assessment of 
the relative importance of these three sources 
of error: finite number of observed cells, 
fluctuations within tumour, and fluctuations 
between tumours. 
The procedure applied is, in essence a com-
parison of the A^ariances of observed values for 
IM and Is with their putative variances 
{\p}jn) resulting from the finite cell count. 
As a first step, one can ask whether the 
variances are significantly larger than the 
putative variances. I f they are, one can go 
further and estimate, from the discrepency 
between observed variance and putative 
variance, the magnitude of the inherent 
variations of IM or 1$. 
Under the null assumption that the 
samples are homogeneous, one finds that 
the sum of the ratios of the actual to the 
putative deviations is distributed as x2 with 
N — 1 degrees of freedom (Snedecor and 
Cochran, 1971): 
N 
V 
i = l 
Pi-i 
(pt - P)2 PI>H 
pm — S rt 
(1) 
i=l 
Where the samples can have different 
sizes and where p — Zr^/Zn^. I n the 
following sections, experimental results will 
be compared with the theoretical distribution 
of x 2 . 
I n those cases where the observed x2 *s 
significantly larger than expected, the con-
tribution of the two different types of 
statistical fluctuation can be estimated. 
This is done in the following way. 
Let cr0bs D e the observed standard deviation 
in a group of N samples 
X 11/2 
S (Pi - P)2 o~obs = (N - I ) " 1 / 2 
x (N - I ) " 1 / 2 
1/2 (2) 
where p% are the observed values and p 
is their average. Since the inherent fluctua-
tions and the fluctuations due to the finite 
cell count are independent, one can assume 
that the observed variance a0bs2 is the 
sum of the inherent variance a 2 of IM or 
Is and the putative variance <JP2 which 
is due to the finite cell count. 
ffobs2 = ° 2 + °72 (3) 
The putative variance for an individual 
observed value is, as has been stated, 
(py/ni- As an estimate of <j?}, one has to 
* The symbol <p> is used for the expectation value of p {i.e. the index) at a particular site in the tumour, 
while the more commonly used symbol p is reserved for the average of the observed values pt at different 
sites (see Equation (2)). 
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use the observed value pu and one therefore 
obtains the following estimate of av2 for a 
group of samples: 
From Equations (2), (3), and (4) one obtains 
the estimate of the inherent standard 
deviation a of JTM or i g : 
9 9 9 
(J- •— a0hs* — 0p 
V , .V 2 
y n ' - s (fp*) 
_ £ i _ y h _ L _ 1 x p i * 
A I -V Z , n 
i = l 
(5) 
I n the next section these relations wil l be 
applied to the experimental observations. 
R E S U L T S 
Discussion of the analysis in a selected 
example 
The analysis wi l l be il lustrated i n 
detail as applied to the mitot ic index 
in nephroblastoma. I t w i l l then suffice 
to present a table summarizing the results 
for the other tumours. 
I n each of 5 tumours 5 separate samples 
(histological blocks) were evaluated. Ac-
cordingly one may consider two different 
questions. First, we ask whether the 
observed fluctuations wi th in individual 
tumours agree wi th the fluctuations which 
are expected due to sampling error in 
the finite number of cells observed, or 
whether they exceed these putat ive fluc-
tuations. Secondly, we compare the ob-
served fluctuations w i t h the putative 
fluctuations for the totality of the results 
from all 5 tumours. I n this second analysis 
a difference between the observed and 
the putative fluctuations represents the 
influence not only of variations in the 
mitotic index wi th in tumours, but also 
of variations between tumours. 
I n order to analyse the fluctuations 
between different samples (histological 
blocks) wi th in the same tumour, one 
must apply Equation (1) separately for 
each tumour, and then sum the results 
for all 5 tumours. The quanti ty x 2 w i l l 
be wr i t ten w i th the index w to indicate 
tha t i t relates to variations from block 
to block wi th in the same tumour: 
M Xj Xj 
(6) 
I n this formula i is the number of the 
block; j is the number of the tumour; 
M is the number of tumours; Nj is the 
number of blocks observed i n the jth 
tumour. The quantities pj, pifj, and 
Vfj are the values of p, pt, r% (see Equation 
(1)) for the individual tumour. The number 
of degrees of freedom is equal to the tota l 
number of blocks minus M. 
The procedure is illustrated by Table I , 
which shows the mitot ic index, the raw 
data on which the index was based, and 
the results of the v 2 analysis in 5 separate 
sites (blocks) in each of 5 nephroblastomas. 
We see that the within-tumour xiv2 is 
311 w i t h 20 degrees of freedom. The 
probabili ty of the purely chance occur-
rence of such a high value of Y 2 is 
< 0-001; one therefore concludes that 
the fluctuations in mitot ic index from 
block to block are real. 
We now consider the second aspect, 
and analyse the fluctuations over all 
blocks pooled from all 5 nephroblastomas. 
I n this case one applies equation (1) 
for the to ta l i ty of data where p is the 
total observed mean. The index j , which 
refers to the number of the tumour, 
can be omitted and the sum extends 
over the to ta l number, N = 25, of blocks. 
The resulting quanti ty w i l l be wri t ten 
w i t h the index b to indicate that i t 
refers to fluctuations not only wi th in 
tumours bu t also between tumours: 
X62 = ! 2 * i , " « - 2 r < ( 7 ) 
The number of degrees of freedom is 
equal to N - 1. 
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T A B L E I .—Mitotic Index, IM (%), in Sections from Blocks taken at 5 Separate Sites 
in 5 Cases of Advanced ( > 500 g) Nephroblastoma. Number of Mitoses Counted is 
Shown in Brackets 
Block 1 2 3 4 5 
Tumour J M ( % ) ± s.e. 
N l 0-50 0-63 0-68 0-71 1-03 0-71 ± 0 - 0 9 
(225) (291) (244) (305) (365) 
N2 0-61 0-66 0-69 0-72 0-79 0-69 + 0-03 
(318) (305) (292) (328) (290) 
N3 0-72 0-86 0-97 1 0 5 1-43 101 + 0-12 
(301) (407) (424) (494) (662) 
N4 0-78 1 00 1-03 1-09 1-14 l - 0 1 ± 0 - 0 6 
(425) (418) (444) (494) (494) 
N5 1 0 6 1-08 1-10 1-36 1-50 1-22 + 0-09 
(325) (526) (526) (532) (525) 
Total: 0 - 9 3 ± 0 - l l 
Fluctuations within tumours: 
Xw2 = 311; d.f. 20; P < 0-001. 
ffobs = 0-19%; op = 0-05%; a = 0-18%. 
Fluctuations between tumours: 
Xb2 = 782; d.f. = 24; P < 0-001. 
aobs = 0-27%; op = 0-05%; o = 0-26%. 
Parallel labelling studies were not made on these blocks, but studies on 3 comparable tumours have 
been reported by Camplejohn and Aherne (1974); these gave i s = 34-5%, 15-8% and 22-1%. 
The resulting value is vV2 = 7 8 2 w i t h 
24 degrees of freedom. The probabili ty 
of a random value as large as this is 
far below 0-001. The variations of the 
mitot ic index between different tumours 
are even larger than those wi th in tumours. 
I n the last column of the table, the 
mean of the observations is given for 
each tumour together w i t h its standard 
error. The latter is equal to o0\iS/\/N' 
(see Equation (2)). From these values 
one can already estimate the systematic 
fluctuations of IM between tumours. 
I t is, however, of interest to assess the 
fluctuations wi th in tumours and between 
tumours quantitatively by using Equa-
tions (2), (4) and (5). 
I f one analyses the 5 tumours separately 
one obtains for each tumour the 3 values 
tfobs2? o-p2 and a 2. The averages of these 
values for the 5 tumours are calculated 
and the resulting standard deviations 
(o"obs> vp, and a) are given in Table I . 
For the observed standard deviation one 
obtains a 0bs = 0-19%. The putative 
standard deviation due to the finite cell 
count is op = 0-05%. The estimated 
standard deviation of the actual fluctua-
tions of IM between blocks in the same 
tumour is o = 0-18%. 
For convenience, both the values of 
IM and of the standard deviations are 
given in % of the total cell number. 
One must note that the standard devia-
tions are not given as per cent of the 
index IM-
One finds that a in this case substanti-
ally exceeds the putative fluctuations 
op due to the finite cell count. I t follows 
that the cell count could have been 
reduced in this experiment w i t h very 
l i t t le loss of statistical accuracy. I n 
order to improve the accuracy one would 
have to examine more blocks per tumour. 
I f one pools all samples from the 5 
different tumours, one obtains an observed 
standard deviation of the samples from 
their common mean, IM = 0*93%, which 
has the value o-0bs = 0-27%. The putative 
standard deviation due to the finite 
cell count remains unchanged at 0-05%, 
and the estimated inherent standard 
deviation of IM in the various blocks from 
the common mean has the value 
o =0 -26%. I t is therefore substantially 
larger than the fluctuations w i t h i n tumours. 
T A B L E II .—Summary of Results for Mammary Carcinoma (Primary and Metastatic) and for Primary Colorectal Carcinoma 
(a) Mitotic index 
Tumour type 
Primary invasive 
mammary carcinoma 
Metastatic mammary 
carcinoma (lymph 
node deposits) 
Primary colorectal 
carcinoma 
(b) Labelling index 
Primary invasive 
mammary carcinoma 
Metastatic mammary 
carcinoma (lymph 
node deposits) 
Number 
of 
tumours 
Number 
of sites 
per 
tumour 
7-9 
10 
6-9 
Mean 
mitotic 
index for 
group of 
tumours 
(hi) 
(251)* 
0-4% 
(275) 
0-86% 
(908) 
0-91% 
Mean 
labelling 
index for 
group of 
tumours 
(Is) 
(626) 
2-45% 
(2199) 
8'0% 
Cobs 
Xw~ = 
c 0 bs 
Cobs 
^obs 
Fluctuations within tumours 
27; d.f. 19; 0-1 < P < 0-2 
28; d.f. 14; P < 0 0 4 
= 0-34%; ap = 0-21%; a • 
70; d.f. 18; P < 0-001 
0-26%; ap = 0-13%; c 0-22% 
Cobs 
120; d.f. 16; P < 0-001 
: 1-3%; ap = 0-5%; a = 1-2% 
122; d.f. 13; P < 0 001 
: 2-6%; ap = 0-7%; a = 
xi>-
Fluctuations between tumours 
= 81; d.f. 23; P < 0-001 
Xb2 = 103; d.f. 15; P < 0-001 
c o b s = 0-53%; ap = 0-21%; a = 0-41% 
Xb2 = 71; d.f. 19; P < 0-001 
aous = 0-26%; ap = 0-13%; a - 0-22% 
Xb' 2 = 349; d.f. 19; P < 0-001 
cobs = 1'9%; op = 0-5%; a = 1-
Cobs 2-5% 
* ( ) Figure in brackets represents the total number of mitoses or labelled cells recorded for each group of tumours. 
265; d.f 14; P < 0 001 
3-1%; ap = 0-7%; a = 3-0% 
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The results for the remaining cases 
are summarized in Table I I . I t is evident 
that the values of Y 2 , w i t h one exception, 
are significantly different from the values 
expected as a result of sampling error. 
The exception is the set of results for 
the within-tumour fluctuation of the 
mitotic index in pr imary mammary car-
cinoma (Table I I ) . I n this case only 
few mitoses were observed. The standard 
deviation ov due to the finite cell count 
is therefore so large that i t masks the 
inherent fluctuations of 7M- A n estimated 
value of the inherent standard deviation 
a = 0-08% is nevertheless given. Since 
this estimate is subject to considerable 
uncertainty, i t is set i n brackets. 
The variation over axil lary metastatic 
mammary carcinoma i n two cases was 
also examined, these being the only 
suitable cases in our material now that 
radical mastectomy is less common. I n 
this case, quite significant contributions 
of the systematic variations are found; 
the results are also given i n Table I I . 
The mitotic index in the metastatic 
deposits of mammary carcinoma was 
significantly greater than the mitot ic 
index in the primary tumours. 
Mammary carcinoma is the only tumour 
whose labelling index we were able to 
estimate and analyse in this study. 
C O M M E N T 
A t least in colorectal carcinoma and 
nephroblastoma, there are real differences 
in mitotic act ivi ty from site to site wi th in 
each, tumour and between tumours of 
indistinguishable histological type. The 
same may be true of the labelling index in 
mammary carcinoma. 
I n mammary carcinomas the mitot ic 
counts were too low to permit accurate 
assessment of the inherent variations i n 
/jvi- There is, however, no indication 
that inherent fluctuations are absent i n 
this case. 
The major i ty of cytokinetic measures 
used to characterize cell populations are 
based on proportions of mitoses (or 
metaphases) and proportions of labelled 
cells. I n the l ight of our findings i t 
appears difficult to obtain tissue samples 
which represent tumours unequivocally, 
at least i n man. We have no reason to 
suppose that the tumours we studied 
are exceptional. Indeed, large variations 
i n proliferative indices, in both human 
and animal tumours, have been reported 
by a number of authors. I t has been 
shown that proliferative act ivi ty at a 
site depends upon a variety of factors 
such as p rox imi ty to a blood vessel or 
pheripheral or central position (e.g. Her-
rn ens and Barendsen, 1967; Shirakawa et 
al, 1970; Tannock, 1968). The aim of 
the present paper is to provide a method 
of assessing the relative magnitude of 
inherent and statistical variations. I t is 
hoped that this technique could prove 
useful in the planning and evaluation 
of cell kinetic studies. 
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